877
Views
38
CrossRef citations to date
0
Altmetric
Research Article

Continuous direct tablet compression: effects of impeller rotation rate, total feed rate and drug content on the tablet properties and drug release

, , , , , & show all
Pages 1802-1808 | Received 15 May 2012, Accepted 04 Oct 2012, Published online: 19 Nov 2012

References

  • Leuenberger H. (2001). New trends in the production of pharmaceutical granules: batch versus continuous processing. Eur J Pharm Biopharm, 52:289–296.
  • Gonnissen Y, Gonçalves SI, De Geest BG, Remon JP, Vervaet C. (2008). Process design applied to optimise a directly compressible powder produced via a continuous manufacturing process. Eur J Pharm Biopharm, 68:760–770.
  • Vanarase AU, Muzzio FJ. (2011). Effect of operating conditions and design parameters in a continuous powder mixer. Powder Technol 208:26–36.
  • Koblitz T, Ehrhardt L. (1985). Continuous variable-frequency fluid bed drying of pharmaceutical granulations. Pharm Technol 9:62–81.
  • Van Melkebeke B, Vervaet C, Remon JP. (2008). Validation of a continuous granulation process using a twin-screw extruder. Int J Pharm, 356:224–230.
  • Portillo PM, Ierapetritou MG, Muzzio FJ. (2009). Effects of rotation rate, mixing angle, and cohesion in two continuous powder mixers – A statistical approach. Powder Technol 194:217–227.
  • Augsburger LL, Zellhofer MJ. (2002). Tablet formulation. In: Swarbrick J, Boylan JC, editors. Encyclopedia of Pharmaceutical Technology. 2nd ed. New York: Marcel Decker Inc, 2705–2707.
  • Pingali KC, Saranteas K, Foroughi R, Muzzio FJ. (2009). Practical methods for improving flow properties of active pharmaceutical ingredients. Drug Dev Ind Pharm, 35:1460–1469.
  • Doelker E. (1993). Comparative compaction properties of various microcrystalline cellulose types and generic products. Drug Dev Ind Pharm 19:2399–2471.
  • Llusa M, Levin M, Snee RD, Muzzio FJ. (2010). Measuring the hydrophobicity of lubricated blends of pharmaceutical excipients. Powder Technol 198:101–107.
  • Berthiaux H, Marikh K, Gatumel C. (2008). Continuous mixing of powder mixtures with pharmaceutical process constraints. Chem Eng Process 47:2315–2322.
  • Gao Y, Vanarase A, Muzzio F, Ierapetritou M. (2011). Characterizing continuous powder mixing using residence time distribution. Chem Eng Sci 66:417–425.
  • Portillo PM, Ierapetritou MG, Muzzio FJ. (2008). Characterization of continuous convective powder mixing processes. Powder Technol 182:368–378.
  • EDQM. (2010). European Pharmacopoea. 7.0th edition (and supplement 7.4). Vol 1. Strasbourg Cedex: Council of Europe.
  • United States Pharmacopeial Convention. (2003). USP 27 The United States Pharmacopeia (2004)/NF 22 The National Formulary. 27th and 22nd editions. Toronto: United States Pharmacopeial Convention Inc. Webcom Ltd.
  • Augsburger LL, Hoag SW, editors. (2008). Pharmaceutical Dosage Forms: Tablets. Vol 3. Manufacturing and Process Control. 3rd edition. Oxfordshire: Taylor & Francis, 211.
  • Siegel S, Castellan NJ, Jr. (1988). Nonparametric statistics for the behavioral sciences. 2nd ed. New York: McGraw-Hill Book Company, 213–215.
  • Sonnergaard JM. (2002). Distribution of crushing strength of tablets. Eur J Pharm Biopharm, 53:353–359.
  • Busignies V, Leclerc B, Truchon S, Tchoreloff P. (2011). Changes in the specific surface area of tablets composed of pharmaceutical materials with various deformation behaviors. Drug Dev Ind Pharm, 37:225–233.
  • Augsburger LL, Hoag SW.( 2008). Compression and compaction. In: Pharmaceutical dosage forms: Tablets. Volume 1: Unit Operations and Mechanical Properties. 3rd edition. New York: Informa Healthcare, 556–571.
  • Mohammed H, Briscoe BJ, Pitt KG. (2006). A study on the coherence of compacted binary composites of microcrystalline cellulose and paracetamol. Eur J Pharm Biopharm, 63:19–25.
  • Rowe RC, Sheskey PJ, Cook WG, Fenton ME, editors. (2012). Cellulose, microcrystalline. In: Sun CC, editor. Handbook of Pharmaceutical Excipients. 7th ed. Pharmaceutical Press and American Pharmacists Association. Available at: http://www.medicinescomplete.com/mc/excipients/current/1001935557.htm
  • Llusa M, Levin M, Snee RD, Muzzio FJ. (2009). Shear-induced APAP de-agglomeration. Drug Dev Ind Pharm, 35:1487–1495.
  • FDA. (2000). Guidance for industry: Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070246.pdf

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.